Age-related deregulation of TDP-43 after stroke enhances NF-κB-mediated inflammation and neuronal damage.

Together, our findings suggest that the level of cytoplasmic TDP-43 increases with aging and may act as an age-related mediator of inflammation and neuronal injury after stroke. Thus, targeting cytoplasmic TDP-43 may have a therapeutic potential after stroke.